Novartis Targets Teva Over Myfortic Patents
Novartis AG accused Israeli generics maker Teva Pharmaceutical Industries Ltd. in Delaware on Wednesday of infringing a group of its patents related to immunosuppressive agent Myfortic....To view the full article, register now.
Already a subscriber? Click here to view full article